Cargando…
Complete Resolution of a Large, Locally-advanced Cutaneous Squamous Cell Carcinoma with the Immune-modulating PD-1 Inhibitor Pembrolizumab
Locally advanced cutaneous squamous cell carcinoma (cSCC) represents a challenge in treatment. Only very recently (February 2020) have guidelines been released regarding the management of unresectable, locally advanced cSCC. With the introduction of check point inhibitors during the last decade, ant...
Autores principales: | Cristancho, Cagney, Riano, Ivy, Guareras-Paredes, Daniel, Park, Robin, Seetharaman, Kala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290116/ https://www.ncbi.nlm.nih.gov/pubmed/32542127 http://dx.doi.org/10.7759/cureus.8072 |
Ejemplares similares
-
Stevens-Johnson Syndrome–Like Reaction After Exposure to
Pembrolizumab and Recombinant Zoster Vaccine in a Patient With Metastatic Lung
Cancer
por: Riano, Ivy, et al.
Publicado: (2020) -
Pembrolizumab-Induced Vitiligo in Esophageal Squamous Cell Carcinoma Patient With Durable Complete Response
por: Wilkins, Matthew C, et al.
Publicado: (2021) -
Metastatic Porocarcinoma Effectively Managed by Pembrolizumab
por: Singh, Arminder, et al.
Publicado: (2021) -
Cutaneous Squamous Cell Carcinoma in Lynch Syndrome — An Overlooked Association
por: Moorthy, Vivek, et al.
Publicado: (2021) -
Voriconazole Induced Cutaneous Squamous Cell Carcinoma in an Immunocompetent Patient
por: Parza, Kevin, et al.
Publicado: (2022)